Estroprogestinici orali a basso dosaggio ed embolia polmonare

Descrizione di un caso clinico

Translated title of the contribution: Low-dose oral contraceptives and pulmonary embolism: A case report

Paolo Rossi, Antonio Attanasio, Ambrogio Capria, Mario D'Uva, Mario Sangiorgi

Research output: Contribution to journalArticle

Abstract

We have observed a deep venous thrombosis with pulmonary embolism in a young woman receiving low-dose oral contraceptives; this adverse drug effect was not associated with some risk factor and, in particular, with a demonstrable congenital or acquired clotting abnormality. It is reported that EP can induce deep venous thrombosis with different mechanisms, as hemoreological changes with subsequent poor clearance of locally activated clotting factors, or an increase of platelet or leukocytes aggregation, or a direct effect on some clotting factor; furthermore, it is well shown that oral contraceptives may induce antibodies to synthetic hormones, with detection of circulating immune complexes, that might produce thrombosis by damaging the vascular endothelium or interfering with clotting factors or platelet aggregation. Moreover, only a familial history of thrombosis or a past history of recurrent deep venous thrombosis, especially in young age, may justify a broad and highly expensive screening of latent clotting abnormalities, that may significantly increase the risk of vascular thrombosis with the use of oral contraceptives.

Original languageItalian
Pages (from-to)3-7
Number of pages5
JournalClinica Terapeutica
Volume147
Issue number1-2
Publication statusPublished - 1996

Fingerprint

Blood Coagulation Factors
Oral Contraceptives
Pulmonary Embolism
Venous Thrombosis
Thrombosis
Vascular Endothelium
Antigen-Antibody Complex
Platelet Aggregation
Blood Vessels
Leukocytes
Blood Platelets
Hormones
Antibodies
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rossi, P., Attanasio, A., Capria, A., D'Uva, M., & Sangiorgi, M. (1996). Estroprogestinici orali a basso dosaggio ed embolia polmonare: Descrizione di un caso clinico. Clinica Terapeutica, 147(1-2), 3-7.

Estroprogestinici orali a basso dosaggio ed embolia polmonare : Descrizione di un caso clinico. / Rossi, Paolo; Attanasio, Antonio; Capria, Ambrogio; D'Uva, Mario; Sangiorgi, Mario.

In: Clinica Terapeutica, Vol. 147, No. 1-2, 1996, p. 3-7.

Research output: Contribution to journalArticle

Rossi, P, Attanasio, A, Capria, A, D'Uva, M & Sangiorgi, M 1996, 'Estroprogestinici orali a basso dosaggio ed embolia polmonare: Descrizione di un caso clinico', Clinica Terapeutica, vol. 147, no. 1-2, pp. 3-7.
Rossi, Paolo ; Attanasio, Antonio ; Capria, Ambrogio ; D'Uva, Mario ; Sangiorgi, Mario. / Estroprogestinici orali a basso dosaggio ed embolia polmonare : Descrizione di un caso clinico. In: Clinica Terapeutica. 1996 ; Vol. 147, No. 1-2. pp. 3-7.
@article{c7a883eadc2e4c52b7221c6ca194c8f2,
title = "Estroprogestinici orali a basso dosaggio ed embolia polmonare: Descrizione di un caso clinico",
abstract = "We have observed a deep venous thrombosis with pulmonary embolism in a young woman receiving low-dose oral contraceptives; this adverse drug effect was not associated with some risk factor and, in particular, with a demonstrable congenital or acquired clotting abnormality. It is reported that EP can induce deep venous thrombosis with different mechanisms, as hemoreological changes with subsequent poor clearance of locally activated clotting factors, or an increase of platelet or leukocytes aggregation, or a direct effect on some clotting factor; furthermore, it is well shown that oral contraceptives may induce antibodies to synthetic hormones, with detection of circulating immune complexes, that might produce thrombosis by damaging the vascular endothelium or interfering with clotting factors or platelet aggregation. Moreover, only a familial history of thrombosis or a past history of recurrent deep venous thrombosis, especially in young age, may justify a broad and highly expensive screening of latent clotting abnormalities, that may significantly increase the risk of vascular thrombosis with the use of oral contraceptives.",
keywords = "oral contraceptives, pulmonary embolism",
author = "Paolo Rossi and Antonio Attanasio and Ambrogio Capria and Mario D'Uva and Mario Sangiorgi",
year = "1996",
language = "Italian",
volume = "147",
pages = "3--7",
journal = "Clinica Terapeutica",
issn = "0009-9074",
publisher = "Societa Editrice Universo",
number = "1-2",

}

TY - JOUR

T1 - Estroprogestinici orali a basso dosaggio ed embolia polmonare

T2 - Descrizione di un caso clinico

AU - Rossi, Paolo

AU - Attanasio, Antonio

AU - Capria, Ambrogio

AU - D'Uva, Mario

AU - Sangiorgi, Mario

PY - 1996

Y1 - 1996

N2 - We have observed a deep venous thrombosis with pulmonary embolism in a young woman receiving low-dose oral contraceptives; this adverse drug effect was not associated with some risk factor and, in particular, with a demonstrable congenital or acquired clotting abnormality. It is reported that EP can induce deep venous thrombosis with different mechanisms, as hemoreological changes with subsequent poor clearance of locally activated clotting factors, or an increase of platelet or leukocytes aggregation, or a direct effect on some clotting factor; furthermore, it is well shown that oral contraceptives may induce antibodies to synthetic hormones, with detection of circulating immune complexes, that might produce thrombosis by damaging the vascular endothelium or interfering with clotting factors or platelet aggregation. Moreover, only a familial history of thrombosis or a past history of recurrent deep venous thrombosis, especially in young age, may justify a broad and highly expensive screening of latent clotting abnormalities, that may significantly increase the risk of vascular thrombosis with the use of oral contraceptives.

AB - We have observed a deep venous thrombosis with pulmonary embolism in a young woman receiving low-dose oral contraceptives; this adverse drug effect was not associated with some risk factor and, in particular, with a demonstrable congenital or acquired clotting abnormality. It is reported that EP can induce deep venous thrombosis with different mechanisms, as hemoreological changes with subsequent poor clearance of locally activated clotting factors, or an increase of platelet or leukocytes aggregation, or a direct effect on some clotting factor; furthermore, it is well shown that oral contraceptives may induce antibodies to synthetic hormones, with detection of circulating immune complexes, that might produce thrombosis by damaging the vascular endothelium or interfering with clotting factors or platelet aggregation. Moreover, only a familial history of thrombosis or a past history of recurrent deep venous thrombosis, especially in young age, may justify a broad and highly expensive screening of latent clotting abnormalities, that may significantly increase the risk of vascular thrombosis with the use of oral contraceptives.

KW - oral contraceptives

KW - pulmonary embolism

UR - http://www.scopus.com/inward/record.url?scp=0029822525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029822525&partnerID=8YFLogxK

M3 - Articolo

VL - 147

SP - 3

EP - 7

JO - Clinica Terapeutica

JF - Clinica Terapeutica

SN - 0009-9074

IS - 1-2

ER -